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ERCP-EUS single session. Also, the issues of learning curves 
and education of upcoming biliopancreatic endoscopists 
are highlighted. Conclusion: In recent years the comple-
mentation between ECRP and EUS has been growing both 
from a diagnostic and a therapeutic point of view, allowing 
optimization of the use of these techniques and the creation 
of a more systematized approach of patients with bilio-
pancreatic pathology. Endoscopists with experience in both 
techniques will be increasingly important, suggesting a par-
allel formation in the training plans of future endoscopists 
with interest in the area.
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Abstract
Background: Endoscopic retrograde cholangiopancreatog-
raphy (ERCP) and endoscopic ultrasound (EUS) were initially 
introduced into the world of gastroenterology as purely di-
agnostic procedures. With progressive evolution of inter-
vention, both these techniques conquered fields in the treat-
ment of many conditions that had once been exclusively sur-
gical domains. Nowadays, more and more clinical situations 
have an indication to perform both EUS and ERCP, and these 
two techniques are frequently required at the same time for 
the same patient. More than competitors, ERCP and EUS are 
truly complementary, with great ability for mutual aid. They 
share their main indications, equipment, accessories, and 
main technical gestures. Objectives and Methods: We re-
view the major indications to perform both techniques, se-
quentially or complementarily, describe the common things 
that these two techniques essentially share, and discuss the 
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Introdução: A colangiopancreatografia retrógrada en-
doscópica (CPRE) e a ultrassonografia endoscópica (EUS) 
foram introduzidas no mundo da Gastrenterologia há al-
gumas décadas, inicialmente como procedimentos pura-
mente diagnósticos. Com a evolução progressiva na área 
da intervenção, estas duas técnicas conquistaram terreno 
no tratamento de muitas patologias que, outrora, eram 
exclusivamente do domínio cirúrgico. Atualmente, cada 
vez mais situações clínicas têm indicação para a realização 
de EUS e CPRE e, frequentemente, ambas são solicitadas 
ao mesmo tempo para um mesmo doente, a realizar ideal-
mente em sessão anestésica única. Mais do que concor-
rentes, a CPRE e a EUS são técnicas verdadeiramente com-
plementares, com elevada capacidade de interajuda. 
Compartilham as suas indicações mais frequentes, equi-
pamentos e acessórios, bem como os principais gestos 
técnicos. As duas técnicas têm, também, em comum cur-
vas de aprendizagem bastante exigentes. Objetivos e 
métodos: O presente artigo tem como objetivo rever as 
principais indicações para a realização de EUS e CPRE, se-
quencialmente ou de forma complementar, descrever os 
aspetos comuns a ambas as técnicas e discutir o conceito 
de EUS-CPRE em sessão única. São ainda equacionados os 
desafios futuros, com especial foco nas questões relativas 
à formação dos futuros gastrenterologistas, de modo a 
promover o contínuo aperfeiçoamento da endoscopia bi-
liopancreática, diagnóstica e terapêutica. Conclusão: Nos 
recentes anos a complementação entre a ECRP e a EUS 
tem vindo a crescer tanto do ponto de vista diagnóstico, 
como terapêutico, permitindo uma optimização da utili-
zação destas técnicas e a criação de uma abordagem mais 
sistematizada dos doentes com patologia biliopancreáti-
ca. Endoscopistas com experiência em ambas as técnicas 
serão cada vez mais importantes, sugerindo-se uma for-
mação paralela nos planos de formação de futuros endos-
copistas com interesse na área.
© 2017 Sociedade Portuguesa de Gastrenterologia 
Publicado por S. Karger AG, Basel
Introduction
Endoscopic retrograde cholangiopancreatography 
(ERCP) was introduced in the world of gastroenterology 
four decades ago initially as a purely diagnostic procedure, 
but after the development of endoscopic sphincterotomy 
and increasingly complex techniques, it moved to the 
therapeutic area. Furthermore, the emergence and rapid 
improvement of less invasive imaging modalities, such as 
computed tomography, magnetic resonance cholangio-
pancreatography, and endoscopic ultrasound (EUS), re-
placed ERCP in its diagnostic role. In fact, this technique 
is mainly considered a therapeutic procedure. Despite this 
“shift” to intervention, the main indications for its perfor-
mance have not changed, namely cholelithiasis and its 
complications, biliary and pancreatic ductal abnormali-
ties, and ampullary/periampullary lesions [1, 2].
EUS was introduced in the 1980s, with the first scopes 
with mechanical technology and radial scan. As ERCP, 
EUS was restricted to a purely diagnostic technique at the 
beginning. In the early 1990s, after the appearance of the 
first linear scope, it became possible to perform EUS-guid-
ed fine needle aspiration (FNA). It also opened the gate to 
exploring the gut wall and the peridigestive organs and 
spaces, either for diagnostic or therapeutic purposes. The 
development of electronic transducers led to the ability to 
improve ultrasound imaging, allowing Doppler function, 
double harmonic and, more recently, elastography and 
echo contrasts. The evolution of the scopes’ lumen work-
ing channels and FNA needles caliber, namely the emer-
gence of the 19G needle, has turned EUS into a modality 
that combines an important diagnostic accuracy, playing 
a role in locoregional staging of a wide range of malignan-
cies, with an increasing number of therapeutic procedures 
[3]. These intervention techniques include drainage pro-
cedures of biliary and pancreatic ducts, peridigestive col-
lections, interluminal anastomoses and, more recently, 
antitumor therapies and vascular interventions [3]. Much 
of this long and auspicious way was simplified by the fact 
that EUS procedures share numerous devices and acces-
sories used and developed for ERCP [4].
What Do These Techniques Essentially Share?
Importantly, they are both advanced endoscopic tech-
niques. Their history was common, starting in the diag-
nostic field with progressive evolution to intervention, 
conquering fields in the treatment of many conditions 
that had once been exclusively part of the surgical do-
main. Many of their associated procedures have in fact 
significant levels of invasiveness, with inevitable associ-
ated risks of adverse events and complications.
Above all, they also share one of their main indications: 
biliopancreatic pathology. In this field, they are two tech-
niques that more than competitors; they are truly comple-
mentary, with great ability for mutual aid. Therefore, it is 
not surprising that more and more, in several clinical situ-
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ations, they are being requested at the same time for the 
same patient, and the once called ERCP room facility 
should include standing equipment for therapeutic EUS.
There is thus a convergence of nosological interests 
and the capacity to contribute to their diagnosis and treat-
ment, through the use of similar equipment (duodeno-
scope and linear echoendoscope) and common accesso-
ries and devices (such as guidewires, stents, and contrasts) 
that allow performance of complex maneuvers, of course 
with inherent risks of adverse events. In fact, the technical 
evolution of the scopes and devices ran parallel for both 
modalities, with improvements in each of them contrib-
uting to progresses in its counterpart.
The similitude of equipment, accessories, and main 
technical gestures is such that they both share the need 
of having a dedicated and experienced team, especially 
nurses with properly advanced training in endoscopy and 
anesthesiologists fully orientated to these patients, and 
specific procedures [5]. In both, outcomes after diagnos-
tic and/or therapeutic endoscopy are influenced by en-
doscopists’ level of expertise and the center’s case volume.
Learning Curves
As advanced techniques, their learning curves are 
steep and very demanding [6, 7]. The programs of educa-
tion of learning ERCP and EUS, both in the internship 
and in the postgraduation period, should consider that 
for those really interested in interventional endoscopy, 
the next level for acquisition of skills should be concur-
rent and complementary in both techniques, specially fo-
cused on biliopancreatic diseases.
Endoscopic Retrograde Cholangiopancreatography
Implementing a standardized protocol for an ERCP 
training program is very difficult and might not be fea-
sible in practice. Procedure volume, indications, and 
technical approaches vary widely among different coun-
tries, institutions, and even endoscopists in one institu-
tion. Competence has been classically evaluated accord-
ing to a minimum number of procedures performed, and 
the number of procedures recommended in most train-
ing programs ranges from 100 to 200. In particular, the 
American Society for Gastrointestinal Endoscopy (ASGE) 
recommends a minimum of 180–200 ERCPs [8].
However, a more dedicated perspective of the quality 
of procedures is lacking, which is not necessarily the result 
of a greater number of procedures. Current research sup-
ports establishing a standard of 80–90% technical success 
before trainees are deemed competent in a specific skill 
[9]. Nevertheless, individual trainees may differ in the ac-
quisition of technical skills. Therefore, these threshold 
numbers might be inadequate. Recently, a study reported 
the use of a standardized form for continuous self-assess-
ment. The form included previously proposed quality in-
dicators for ERCP such as procedural indication, degree 
of technical difficulty, previous ERCP failure, and success 
or failure options (such as cannulation of the common bile 
duct [CBD] or pancreatic duct, stent placement, sphinc-
terotomy, and stone extraction) [9]. This method allowed 
not only for the quantitative evaluation of trainees, but 
also determined the learning curve of each individual and 
of the average group progression. As such, current train-
ing should probably be based on learning curves, although 
more studies are needed to validate these resources.
Endoscopic Ultrasound
The limited availability of EUS is largely the result of a 
lack of skilled endosonographers. A relative lack of train-
ing centers combined with the extensive commitment re-
quired by the trainee has limited the growth of EUS and 
its availability in community practice. For most train- 
ees, the amount of EUS exposure and training is highly 
variable and often program-dependent. Many fellowship 
programs do not provide the opportunity to learn EUS.
The ASGE recommends a minimum of 150 total su-
pervised procedures, 75 of which should be pancreatobil-
iary and 50 FNA (25 of which pancreatic FNA) before 
competency can be determined [10]. The learning pro-
cess of EUS-FNA has been studied for solid pancreatic 
lesions: a learning curve with increasing sensitivity in the 
cytopathological diagnosis of cancer (reaching 80% after 
20–30 EUS-FNA), with a decreasing number of passes 
needed (median of 3 after 150 EUS-FNA). Also, trainees 
should demonstrate competence in linear EUS before un-
dertaking EUS-FNA. In Europe, the European Society of 
Gastrointestinal Endoscopy (ESGE) endorses the use of a 
combination of different simulators and, if available, live 
pigs during training in EUS-FNA [11]. A minimum of 
20–30 supervised nonpancreatic and pancreatic lesions, 
respectively, should be performed with rapid on-site cy-
topathological examination.
Common Indications
There is an increasing number of pathologies which 
benefit from a common EUS-ERCP approach. The most 
frequent one is biliary stone disease and its complications. 
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In Table 1, the indications for the joint use of ERCP and 
EUS are summarized.
Choledocholithiasis
As it is undisputed that ERCP is the technique of 
choice for the treatment of choledocholithiasis, recent 
randomized trials have proven the benefit of performing 
a previous diagnostic examination in order to confirm the 
presence of calculi in the CBD, especially in subjects with 
“intermediate risk” for it (CBD dilation with normal liver 
tests or abnormal liver tests with normal-caliber biliary 
system) [12]. Among these techniques, magnetic reso-
nance cholangiopancreatography and EUS are good al-
ternatives, the latter being more accurate to detect small 
stones and being the option when MRI is contraindicated 
[13]. In fact, in two extensive meta-analyses using ERCP 
or surgical exploration as criterion standards, EUS re-
vealed a sensitivity of 89–94% and a specificity of 94–95% 
in the evaluation of choledocholithiasis [14, 15]. It is esti-
mated that EUS can be used in selecting patients for ther-
apeutic ERCP, avoiding “diagnostic” ERCPs and their 
complications in 60–75% of cases [4, 16].
The EUS plus ERCP strategy is feasible, effective, and 
safe, with no increase in procedure- or sedation-related 
complications [17, 18]. This is particularly important in 
the case of elderly patients, where reports proved that 
long-time procedures were not related to more adverse 
events [19]. Another interesting group of patients are 
pregnant women. Vohra et al. [20] reported a successful 
single-session EUS-based ERCP in 10 pregnant patients 
with suspected choledocholithiasis. In this case series, 
EUS immediately prior to scheduled ERCP eliminated 
the need for ERCP and also its risks in pregnant wom- 
en with no evidence of choledocholithiasis on EUS. In 
patients with confirmed choledocholithiasis, EUS pro-
vided additional information regarding the location, 
number, and size of bile duct stones, which enabled the 
successful clearance of the bile duct without the use of 
fluoroscopy.
Knowing that cannulation of the papilla with a linear 
EUS scope is difficult and may be not possible in a great 
number of patients, it is very attractive to have a “new” 
EUS scope also designed for biliopancreatic cannulation. 
In 2006, Rocca et al. [21] reported the EUS diagnosis and 
simultaneous endoscopic retrograde cholangiography 
treatment of CBD stones by using an oblique-viewing 
echoendoscope in 19 patients with acute abdominal pain 
associated with increased liver tests. When biliary stones 
or sludge were found, bile duct cannulation and sphinc-
terotomy were performed in the same session. In this 
study, this approach was feasible and safe, providing an 
accurate diagnosis and, at the same time, an appropriate 
treatment of CBD stones. Technical improvements are 
needed so that, in the near future, combined EUS-ERCP 
scopes can be used in the management of patients with 
biliopancreatic diseases.
Diagnosis of Pancreatobiliary Neoplasias
Another group of pathologies in which the roles of 
EUS and ERCP converge is the one related to biliary and 
pancreatic obstructions, particularly when a malignant 
cause is suspected, such as pancreatic head neoplasia. In 
these patients, an EUS-ERCP sequential approach has 
clear advantages, the former with an important role in the 




Patients with intermediate risk for CBD stones, 
defined as CBD dilation with normal liver tests or 
abnormal liver tests with normal-caliber biliary 
system




EUS-ERCP sequential approach for diagnosis and 
staging of the tumor, and subsequent biliary drain-
age




ERCP fails up to 10%
EUS-guided biliary drainage (hepaticogastrosto-
my, choledochoduodenostomy, rendezvous)




Difficult conventional ERCP approach (e.g., Roux-
en-Y gastric bypass)
Enteroscopy-based techniques with variable re-
sults
EUS-guided gastrogastric or jejunogastric fistula 
with lumen-apposing metal stent placement
Ampulloma Sequential approach
EUS: evaluation of endoscopic resectability




Collections associated with disconnected pancre-
atic duct (placement of transpapillary pancreatic 
stent)
CBD, common bile duct; ERCP, endoscopic retrograde chol- 
angiopancreatography; EUS, endoscopic ultrasound.
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correct diagnosis (with the possibility of performing 
FNA) and staging of the tumor, and the latter being the 
technique of choice when biliary drainage is indicated. In 
these cases, the information provided by EUS in relation 
to tumor stage may contribute to the choice of drainage 
modality, namely the option of a plastic or metallic stent 
[4].
Concerning the diagnosis of biliary stricture itself, it is 
agreed that EUS-FNA has higher accuracy than ERCP cy-
tology, especially in cases where there is a mass-forming 
lesion (sensitivity of 43–86%) [22–25]. In fact, albeit 
brush cytology has been the mainstay for suspected ma-
lignant biliary strictures because it is easy and safe to per-
form, the overall sensitivity for cancer is only 30–57% 
[26]. Addition of endobiliary forceps biopsy improves 
sensitivity, but it is time consuming, increases costs, and 
may not be technically feasible [27]. Nevertheless, when 
strictures are not associated with a mass-forming lesion, 
ERCP cytology with or without forceps biopsy seems to 
be superior to EUS-FNA [4]. Another chance for inter-
ventional EUS to come close to ERCP is the exponential-
ly growing indications for interventional EUS in bilio-
pancreatic drainage procedures.
Although it is the preferred technique, ERCP may fail 
or not be possible in up to 10% of cases (anatomical vari-
ants, previous surgeries, tumor extension, operator dis-
ability, etc.) [4, 28]. In this context, EUS is assumed as a 
first-line rescue option, with advantages in relation to 
surgery or percutaneous drainage. In fact, when com-
pared to percutaneous drainage, EUS-guided drainage 
has a similar technical success rate, but fewer procedure-
related adverse events and fewer unscheduled re-inter-
ventions [28].
Ductal Drainage Procedures
In 1996, Wiersema et al. [29] described the first EUS-
guided puncture of the bile duct to perform a diagnostic 
cholangiography. Five years later, Giovannini et al. [30] 
reported the first EUS-guided biliary drainage procedure, 
a bilioduodenal anastomosis. Since then, many refine-
ments in drainage techniques have been observed and, at 
present, EUS is indicated as a procedure of choice in sev-
eral situations, either for biliary and/or pancreatic duct 
access, fluid collections and, more recently, gallbladder 
drainage.
Regarding biliary strictures, more than 1,000 cases 
have been published by now, with technical and clinical 
success rates of 91 and 88%, respectively. The mean over-
all complications (16–35%) and mortality rates (1–5%) 
are variable among series, being higher in the early stages 
of the operator learning curve [4], so these procedures 
should be reserved for tertiary centers with expertise in 
both EUS and therapeutic endoscopy. For EUS-guided 
biliary drainage, depending on the type and location of 
the lesion, the intra- or extrahepatic routes can be used to 
access the ductal system, with similar technical and clini-
cal success rates, although the latter seems to be safer. Af-
ter access, stent placement can be made directly (hepati-
cogastrostomy or choledochoduodenostomy), or through 
a rendezvous procedure with ERCP, if passing a trans-
papillary guidewire is achievable. A third alternative is 
placement of the stent in an anterograde way, through the 
papilla [31].
Pancreatic duct drainage guided by EUS is usually in-
dicated in obstructions due to benign disorders, such as 
stenosis, lithiasis, or postoperative strictures. After main 
pancreatic duct access, usually through the stomach, the 
drainage procedure may equally consist of the placement 
of a stent transluminally (pancreatogastrostomy) or via a 
rendezvous approach together with ERCP.
Pancreatic duct EUS-guided drainage is technically 
more challenging than bile duct drainage, with poorer 
general clinical and technical outcomes (78%) and a high-
er overall complications rate (7–55%), especially when 
the transmural route is used due to the need of more ag-
gressive dilation [28, 32].
Anatomical Changes and Interluminal Anastomosis
Another example of true complementarity between 
the two techniques has emerged for the recently wide-
spread surgical treatment of obesity. In fact, there is an 
increasing number of patients in whom performing an 
ERCP is not anatomically possible. This is the case for 
patients submitted to a Roux-en-Y gastric bypass in 
whom, due to the exclusion of the distal stomach and 
proximal duodenum, the ampulla cannot be accessed via 
the standard ERCP procedure. Single or double balloon 
enteroscopy is an option for these patients; nevertheless, 
the success rates are variable. Recently, Kedia et al. [33] 
described the use of a lumen-apposing metal stent to pro-
vide access to the excluded gastrointestinal tract lumen 
for passage of the duodenoscope for ERCP. This proce-
dure consists in an EUS-guided creation of a gastrogastric 
or jejunogastric fistula via the placement of a lumen-ap-
posing metal stent. In the series of Kedia et al. [33], the 
procedure was successful in all 5 cases studied. Larger 
studies are needed to further assess efficacy, safety, and 
long term follow-up.




Adenomatous lesions of the ampulla are entities that 
also frequently require sequential use of EUS and ERCP. 
EUS is useful in the differential diagnosis of prominent 
ampullas, as the majority of these situations represent 
adenomas or adenocarcinomas. It is also very important 
in determining the endoscopic resectability of these le-
sions, having high accuracy in the evaluation of duodenal 
wall layer invasion as well as biliary and pancreatic intra-
ductal extension [34, 35]. When endoscopic papillecto-
my is considered, ERCP plays a major role in minimizing 
the risk of postprocedure pancreatitis by placing a pro-
phylactic pancreatic plastic stent. On the other hand, in 
advanced and/or unresectable lesions, ERCP is the pro-
cedure of choice for palliation of obstructive jaundice 
[36].
Fluid Collection Drainage
Finally, another situation that can benefit from this 
convergence of interests between EUS and ERCP is that 
of pancreatic/peripancreatic fluid collections. Endosco-
py, with or without EUS guidance, is nowadays consid-
ered the first therapeutic option for transmural drainage 
of postpancreatitis pseudocysts and for walling off necro-
sis, being effective and safe, with lower morbidity and 
mortality when compared to surgical management [37]. 
Nevertheless, when collections are associated with a dis-
connected pancreatic duct, EUS-transmural drainage is 
often incomplete and permanent stenting may be re-
quired. In these situations, a combined approach with 
ERCP can be very useful and highly effective, especially 
in the presence of a partial pancreatic duct disruption 
that can be successfully bridged through the papilla [38, 
39].
EUS-ERCP: Convergence in a Single Session?
As mentioned before, nowadays more and more clini-
cal situations have an indication to perform both EUS and 
ERCP. In fact, these two techniques are often required at 
the same time for the same patient. Combining both in a 
single session is not yet common in routine care and they 
are usually performed on separate days. One of the major 
reasons for this is the lack of an appropriate facility as lo-
gistically adapted unit of endoscopy along with the ab-
sence of a high enough number of well-trained profes-
sionals in both procedures. Nevertheless, evidence exists 
that this reality is about to change and, by now, more than 
1,000 cases of single-session EUS and ERCP have already 
been reported in the literature. It is important to notice 
that these procedures should be performed in centers that 
have a significant volume for proper management.
The majority of studies have shown that this strategy, 
using the same sedation, is effective, safe, shortens hospi-
tal stay, and improves patient comfort, being, undoubt-
edly, clinical and financially cost-effective [4].
EUS Segmentation
With the technical evolution of EUS observed in the 
last decade, the demand for this procedure has increased 
significantly in several fields besides biliopancreatic pa-
thology, in particular in the local staging of malignant and 
premalignant lesions of the digestive tract and in the eval-
uation of pelvic structures, mainly in patients with anal 
disorders. These facts can raise the question of the benefit 
of segmentation of endoscopists in these three areas.
In the authors’ opinion, in tertiary referral centers with 
the possibility of subdifferentiation into different endo-
scopic techniques, the presence of endoscopists dedicated 
to performing EUS in a segmented way can be significant, 
theoretically with greater expertise. In addition, consider-
ing the relevance of endoscopy units prepared for joint 
implementation of EUS and ERCP, this can make the 
most of the endoscopists entirely dedicated to both tech-
niques. Similarly, endoscopists dedicated to endoscopic 
resection of malignant and premalignant gastrointestinal 
lesions by endoscopic mucosal resection or submucosal 
dissection may benefit from expertise in EUS in perform-
ing local staging of these lesions. Finally, in patients with 
anal pathology, performing transanal EUS can assist in 
the evaluation of anatomical abnormalities, such as septic 
processes or sphincter injuries, and can be a routine clin-
ical tool in proctology consultation for physicians dedi-
cated to anorectal disorders.
Nevertheless, in the authors’ view, there will always be 
room for endoscopists who are separately dedicated to 
these techniques. On the one hand, the older endosco-
pists, dedicated to ERCP, may not have the disposal for 
the EUS learning requirements, especially with its long 
learning curve. On the other hand, the presence of endos-
copists dedicated only to EUS in its various indications 
will always be necessary, namely in centers without the 
logistic conditions for ERCP, either alone or in associa-
tion with EUS. In addition, not all clinicians feel comfort-
able performing advanced interventional procedures, es-
pecially because of the technical and physical require-
ments implicated.




Apart from the expected continued technological de-
velopment of equipment and accessories needed for the 
performance of both techniques, the future will imply, 
above all, a critical evolution in the training and develop-
ing skills of new gastroenterologists.
When these techniques were born, we observed the 
differentiation of its pioneers and their followers in each 
of them. With time, the ERCP experts looked to EUS as 
an important input for day-to-day practice and began to 
learn it. On the other hand, EUS experts, especially those 
dedicated to biliopancreatic pathology, also realized that 
gaining experience in ERCP could bring an important ad-
vantage in the performance of the more advanced inter-
ventional techniques.
Taking this into account and having in mind both the 
extremely demanding learning curves and safety as an is-
sue of concern, we believe in a future where the conver-
gence concept will also be seen in the training of upcom-
ing endoscopists.
In our opinion, the modern gastrointestinal fellow-
ships should recognize different levels of training and dif-
ferent types of endoscopists. Those particularly interested 
in this subset of diseases should train specifically both 
EUS and ERCP. We certainly believe that this is the way 
that will allow the continuous improvement of diagnostic 
and therapeutic pancreaticobiliary endoscopy.
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